Physician

Michael Lamont Aikens, MD

According to 2025 Medicare claims, Michael Aikens, MD (NPI: 1427014844) practices internal medicine in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is CENTER FOR VEIN RESTORATION AL LLC (NPI: 1164897427; TIN: 810759730) and primary practice location at 36801-6253. Aikens is affiliated with the Alabama Physician Network, LLC (ACO ID: A3738), participating under the MSSP model.

Aikens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 887 HCPCS/CPT codes, and received $320,475 in Medicare payments. The top billing code was 36482 (Chemical destruction of first incompetent vein of arm or leg using imaging guidance). Part D data shows 124 prescription claims across 49 beneficiaries totaling $226,465 in drug costs, led by Nuzyra (Omadacycline Tosylate). DME data shows 86 claims. Open Payments data shows 17 records totaling $233. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $409,296 and ending at $320,475. Concurrently, Part D prescription costs have fallen sharply in recent years, from $3,050,599 to $226,465. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $92,375 to $33,107.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,010	6,162	$409,296
2016	878	4,673	$308,327
2017	699	3,542	$247,221
2018	571	1,982	$173,408
2019	488	1,859	$371,668
2020	390	1,074	$224,053
2021	161	584	$322,331
2022	203	714	$363,808
2023	184	728	$299,018
2024	199	887	$320,475

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	853	17,246	$3,050,599
2016	809	15,259	$3,877,552
2017	787	12,994	$3,845,896
2018	739	9,653	$3,902,775
2019	570	6,259	$3,328,606
2020	454	4,253	$3,754,849
2021	267	1,094	$411,719
2022	35	74	$12,068
2023	44	73	$47,937
2024	49	124	$226,465

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	67	757	$86,951
2016	26	495	$24,037
2017	19	309	$10,245
2018	N/R	163	$6,122
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	11	11	$6,870
2023	42	82	$36,148
2024	12	86	$11,603

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36482	Chemical destruction of first incompetent vein of arm or leg using imaging guidance	43	57	$1,049
36465	Injection of chemical agent into single incompetent vein of leg using ultrasound guidance	89	213	$827
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	85	85	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	124	272	$81
76942	Ultrasonic guidance for needle placement	40	75	$39

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nuzyra	Omadacycline Tosylate	24	394	$202,993
Eliquis	Apixaban	33	1,230	$23,082
Prednisone	Prednisone	18	132	$36

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0667	Segmental pneumatic appliance for use with pneumatic compressor, full leg	N	12	12	$8,312
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	74	$3,291

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$233	Paratek Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Lamont Aikens, MD?

Tedicare shows public-source Medicare data for Michael Lamont Aikens, MD (NPI 1427014844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Lamont Aikens, MD have ACO affiliation data?

Michael Lamont Aikens, MD is shown with ACO affiliation data for Alabama Physician Network, LLC (MSSP, ACO ID A3738).

What billing organization is linked to Michael Lamont Aikens, MD?

Michael Lamont Aikens, MD is linked to CENTER FOR VEIN RESTORATION AL LLC (billing NPI 1164897427) in the available physician profile data.

Does Michael Lamont Aikens, MD have Open Payments data?

Michael Lamont Aikens, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.